Company: Cipla Ltd. Category: Independent Research

Niraj Shah and Yash Upadhyaya share technical insights on which direction Cipla’s stock may move next.
April 8, 2019, 9:05 a.m.

Cipla holds World's Largest inhalation Portfolio having their presence in over 100 countries. In India Cipla is the top pharmaceutical company selling Urology solutions. weighted average of DCF & PE (80-20) gives a target price of Rs...
Oct. 9, 2017, 4:53 p.m.
Author : Anik Mitra | Publisher:

Cipla’s Q1 result and subsequent management commentary were music to investors’ ears, compared to what its bigger peers had to say
Sept. 6, 2017, 5:07 p.m.

Find the latest research report on Cipla Ltd. On FundsIndia Marketplace
July 19, 2017, 2:28 p.m.
Author : FundsIndia | Publisher:

  • 1